sglt2 glp-1 news Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study SGLT2 Inhibitors vs. GLP-1 Agonists

Best Pract Res Clin Endocrinol Metab 23(4):443452

Lawsuits Over Ozempic, Wegovy, Mounjaro and Other GLP1-RA Drugs May Hinge on Label Warnings Lawyers indicate that that questions about whether the GLP-1 RA medication label warnings adequately disclose the risk of gastroparesis and other severe injuries will play a large role in the growing litigation

And so the concern is even with medications theyll help them lose weight and they may lose weight while theyre on the medications, [but without] long-term changes, when they stop the medication they can regain the weight

Muscle wasting refers to pathologic loss of muscle tissue caused by illness, prolonged undernutrition, immobilization, or systemic disease

doi:10.1016/S0140-6736(22)02033-5 2026 The Author(s)

Why PlexusDx Offers Dual-Compound GLP-Squared for Personalized Options PlexusDx recognizes that some patients require multi-pathway metabolic targeting beyond a single GLP-1 drug